Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses (Q28166727)
scientific article (publication date: 12 January 2004)
Language:
Current Data About Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses
(P31) (Q13442814)

(Q815382)

(P50) (Q63107334)
(P1545) 6
(P1932) Bertram Pitt

(Q60629666)
(P1545) 3
(P1932) Andrew Tonkin

(Q89527500)
(P1545) 1
(P1932) Charles H Hennekens

(Q64858750)
(P1545) 4
(P1932) J Wouter Jukema

(P304) 40-4

(P407) (Q1860)

(P433) 1

(P478) 164

(P577) Monday, January 12, 2004

(P921) (Q815382)

(Q18216)
(P887)

(Q389735)
(P887)

(P1433) (Q177428)

(P1476) "Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses" (language: en)

(P2093) Frank M Sacks
(P1545) 2

Robert P Byington
(P1545) 5

Donald A Berry
(P1545) 7

Scott M Berry
(P1545) 8

Neville F Ford
(P1545) 9

Andrew J Walker
(P1545) 10

Kannan Natarajan
(P1545) 11

Chen Sheng-Lin
(P1545) 12

Frederick T Fiedorek
(P1545) 13

Rene Belder
(P1545) 14

other details
description scientific article (publication date: 12 January 2004)

External Links
(P356) 10.1001/ARCHINTE.164.1.40
(P698) 14718320
(P5875) 8923533